WHY PARTNER?

Want to position yourself at the forefront of autoimmune and inflammatory model optimization?

The inaugural Autoimmune & Inflammatory Models Summit is the first industry focused forum tackling translation gaps in in autoimmune drug development. Uniting leading experts from AbbVie, Bristol Myers Squibb, and Pfizer, this event focuses on in vitro and in vivo models, IND strategies, and FDA compliance precisely where you can add critical value.

This forum delivers direct access to decision-makers evaluating partners for model translatability and regulatory success. For preclinical CROs, assay developers and imaging providers, this is your unmatched opportunity to position your solutions as essential to advancing next-generation therapies. 

EXPLORE THE EVENT GUIDE
REGISTER INTEREST

Autoimmune & Inflammatory Drug Developers Need Your Help With:

Supporting the industry with FDA compliant alternative models to help clients transition from animal models, aligning with upcoming regulatory shifts

Demonstrating proved success and expertise in recapitulating diseases like Inflammatory Bowel Disease, Multiple Sclerosis, Rheumatoid Arthritis, Lupus and others to maximize model optimization

Advanced models, assays and imaging tools to bridge preclinical-human biomarker disparities for accurate efficacy and safety predictions

Overcoming concerns of unreliable models by showcasing rigorous model validation methods to prove reliability and build confidence in new models

Why Partner?

Master the FDA's new model requirements and develop compliant solutions to help biopharma clients successfully transition from animal model testing to alternative approaches

Uncover industry-critical pain points to develop precisely targeted solutions that address your client's most pressing preclinical challenges

Elevate your market position by showcasing differentiated capabilities that address the industry's most pressing translational challenges in autoimmune and inflammatory preclinical development

EVENT GUIDE
GET IN TOUCH